Viewing Study NCT02427620


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-03-01 @ 8:13 PM
Study NCT ID: NCT02427620
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2015-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Blastoid Variant Mantle Cell Lymphoma View
None Mantle Cell Lymphoma View
None Pleomorphic Variant Mantle Cell Lymphoma View
Keywords: